Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells

Sergio Anastasi, Stefano Alemà, Oreste Segatto

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase whose physiological signaling activity regulates the morphogenesis and homeostasis of several tissues from worms to man. In contrast, aberrant signaling caused by overexpression or mutational activation of the EGFR plays a causal role in the pathogenesis of a number of human tumors. The fidelity of EGFR signals, which must be robust enough to convey instructive cues to the cell while also preventing the threat posed by excess receptor activity, is guaranteed by a complex regulatory circuitry. A pervasive role in EGFR regulation is played by endocytosis. Owing to its capacity to instruct degradation of activated EGFRs and reduce receptor expression at the cell surface, endocytosis has been regarded historically as the main cellular mechanism deputed to the attenuation of EGFR signaling. More recently, a great deal of attention has been focused on understanding endocytosis also as an element of spatial regulation of EGFR activity. Herein, we discuss molecular mechanisms controlling EGFR endocytosis, as they relate to the regulation of EGFR signal output and the implementation of EGFR-driven biological programs. We will then focus on reviewing the variegated mechanisms through which the EGFR escapes from downregulation in cancer cells. The emerging picture assigns to faulty endocytosis, in concert with constitutive catalytic activation, a prominent role in the ominous oncogenic conversion of EGFR.

Original languageEnglish
Title of host publicationVesicle Trafficking in Cancer
PublisherSpringer New York
Pages279-302
Number of pages24
Volume9781461465287
ISBN (Print)9781461465287, 1461465273, 9781461465270
DOIs
Publication statusPublished - Jul 1 2013

Fingerprint

Endocytosis
Epidermal Growth Factor Receptor
Receptor Protein-Tyrosine Kinases
Morphogenesis
Cues
Neoplasms
Homeostasis
Down-Regulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anastasi, S., Alemà, S., & Segatto, O. (2013). Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells. In Vesicle Trafficking in Cancer (Vol. 9781461465287, pp. 279-302). Springer New York. https://doi.org/10.1007/978-1-4614-6528-7_14

Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells. / Anastasi, Sergio; Alemà, Stefano; Segatto, Oreste.

Vesicle Trafficking in Cancer. Vol. 9781461465287 Springer New York, 2013. p. 279-302.

Research output: Chapter in Book/Report/Conference proceedingChapter

Anastasi, S, Alemà, S & Segatto, O 2013, Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells. in Vesicle Trafficking in Cancer. vol. 9781461465287, Springer New York, pp. 279-302. https://doi.org/10.1007/978-1-4614-6528-7_14
Anastasi S, Alemà S, Segatto O. Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells. In Vesicle Trafficking in Cancer. Vol. 9781461465287. Springer New York. 2013. p. 279-302 https://doi.org/10.1007/978-1-4614-6528-7_14
Anastasi, Sergio ; Alemà, Stefano ; Segatto, Oreste. / Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells. Vesicle Trafficking in Cancer. Vol. 9781461465287 Springer New York, 2013. pp. 279-302
@inbook{cd5b8d4297dc4f7a94a6f3369d8cba71,
title = "Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells",
abstract = "The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase whose physiological signaling activity regulates the morphogenesis and homeostasis of several tissues from worms to man. In contrast, aberrant signaling caused by overexpression or mutational activation of the EGFR plays a causal role in the pathogenesis of a number of human tumors. The fidelity of EGFR signals, which must be robust enough to convey instructive cues to the cell while also preventing the threat posed by excess receptor activity, is guaranteed by a complex regulatory circuitry. A pervasive role in EGFR regulation is played by endocytosis. Owing to its capacity to instruct degradation of activated EGFRs and reduce receptor expression at the cell surface, endocytosis has been regarded historically as the main cellular mechanism deputed to the attenuation of EGFR signaling. More recently, a great deal of attention has been focused on understanding endocytosis also as an element of spatial regulation of EGFR activity. Herein, we discuss molecular mechanisms controlling EGFR endocytosis, as they relate to the regulation of EGFR signal output and the implementation of EGFR-driven biological programs. We will then focus on reviewing the variegated mechanisms through which the EGFR escapes from downregulation in cancer cells. The emerging picture assigns to faulty endocytosis, in concert with constitutive catalytic activation, a prominent role in the ominous oncogenic conversion of EGFR.",
author = "Sergio Anastasi and Stefano Alem{\`a} and Oreste Segatto",
year = "2013",
month = "7",
day = "1",
doi = "10.1007/978-1-4614-6528-7_14",
language = "English",
isbn = "9781461465287",
volume = "9781461465287",
pages = "279--302",
booktitle = "Vesicle Trafficking in Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Regulation of epidermal growth factor receptor signaling by endocytosis in normal and malignant cells

AU - Anastasi, Sergio

AU - Alemà, Stefano

AU - Segatto, Oreste

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase whose physiological signaling activity regulates the morphogenesis and homeostasis of several tissues from worms to man. In contrast, aberrant signaling caused by overexpression or mutational activation of the EGFR plays a causal role in the pathogenesis of a number of human tumors. The fidelity of EGFR signals, which must be robust enough to convey instructive cues to the cell while also preventing the threat posed by excess receptor activity, is guaranteed by a complex regulatory circuitry. A pervasive role in EGFR regulation is played by endocytosis. Owing to its capacity to instruct degradation of activated EGFRs and reduce receptor expression at the cell surface, endocytosis has been regarded historically as the main cellular mechanism deputed to the attenuation of EGFR signaling. More recently, a great deal of attention has been focused on understanding endocytosis also as an element of spatial regulation of EGFR activity. Herein, we discuss molecular mechanisms controlling EGFR endocytosis, as they relate to the regulation of EGFR signal output and the implementation of EGFR-driven biological programs. We will then focus on reviewing the variegated mechanisms through which the EGFR escapes from downregulation in cancer cells. The emerging picture assigns to faulty endocytosis, in concert with constitutive catalytic activation, a prominent role in the ominous oncogenic conversion of EGFR.

AB - The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase whose physiological signaling activity regulates the morphogenesis and homeostasis of several tissues from worms to man. In contrast, aberrant signaling caused by overexpression or mutational activation of the EGFR plays a causal role in the pathogenesis of a number of human tumors. The fidelity of EGFR signals, which must be robust enough to convey instructive cues to the cell while also preventing the threat posed by excess receptor activity, is guaranteed by a complex regulatory circuitry. A pervasive role in EGFR regulation is played by endocytosis. Owing to its capacity to instruct degradation of activated EGFRs and reduce receptor expression at the cell surface, endocytosis has been regarded historically as the main cellular mechanism deputed to the attenuation of EGFR signaling. More recently, a great deal of attention has been focused on understanding endocytosis also as an element of spatial regulation of EGFR activity. Herein, we discuss molecular mechanisms controlling EGFR endocytosis, as they relate to the regulation of EGFR signal output and the implementation of EGFR-driven biological programs. We will then focus on reviewing the variegated mechanisms through which the EGFR escapes from downregulation in cancer cells. The emerging picture assigns to faulty endocytosis, in concert with constitutive catalytic activation, a prominent role in the ominous oncogenic conversion of EGFR.

UR - http://www.scopus.com/inward/record.url?scp=84949176043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949176043&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6528-7_14

DO - 10.1007/978-1-4614-6528-7_14

M3 - Chapter

SN - 9781461465287

SN - 1461465273

SN - 9781461465270

VL - 9781461465287

SP - 279

EP - 302

BT - Vesicle Trafficking in Cancer

PB - Springer New York

ER -